Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01514864
Title Trial of Dasatinib in Subjects With Advanced Cancers Harboring DDR2 Mutation or Inactivating B-RAF Mutation
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | DEU | CAN

Facility Status City State Zip Country Details
H. Lee Moffitt Cancer & Research Institute Tampa Florida 33612 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Local Institution Barretos Sao Paulo 14784 Brazil Details
Local Institution S?o Paulo Sao Paulo 05403 Brazil Details
The Ottawa Hospital Cancer Centre Ottawa Ontario K1H 8L6 Canada Details
Local Institution Frankfurt 60488 Germany Details
Local Institution Heidelberg 69120 Germany Details
Local Institution Heidelberg 69126 Germany Details
Local Institution Koeln 50924 Germany Details
Local Institution Koeln 50931 Germany Details
Local Institution Gdansk 80-219 Poland Details
Local Institution Lodz 93-509 Poland Details
Local Institution Warsaw 02-781 Poland Details
Local Institution Taipei 112 Taiwan Details
Local Institution Cambridge Cambridgeshire CB2 2QQ United Kingdom Details
Local Institution London Greater London SW3 6JJ United Kingdom Details
Local Institution Manchester Greater Manchester M20 4BX United Kingdom Details
Local Institution Edinburgh Midlothian EH4 2XU United Kingdom Details
Local Institution Sutton Surrey SM2 5PT United Kingdom Details
Local Institution Gwent NP20 2UB United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field